Upper airway edema in 43 patients with hereditary angioedema.

[1]  A. Gompel,et al.  Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[2]  Hong-Yu Zhang,et al.  Clinical features of hereditary angioedema in Chinese patients: new findings and differences from other populations. , 2013, European journal of dermatology : EJD.

[3]  Aasia I. Ghazi,et al.  Hereditary angioedema: epidemiology, management, and role of icatibant , 2013, Biologics : targets & therapy.

[4]  B. Zuraw,et al.  Recognizing and managing hereditary angioedema , 2013, Cleveland Clinic Journal of Medicine.

[5]  A. Sheffer,et al.  Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  M. Cicardi,et al.  Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. , 2012, Allergy and asthma proceedings.

[7]  K. Bork,et al.  Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. , 2012, The Journal of allergy and clinical immunology.

[8]  J. Anon.  Hereditary Angioedema: A Clinical Review for the Otolaryngologist , 2011, Ear, nose, & throat journal.

[9]  H. Farkas,et al.  Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema. , 2010, Clinical immunology.

[10]  E. Papadopoulou-Alataki.  Upper airway considerations in hereditary angioedema , 2010, Current opinion in allergy and clinical immunology.

[11]  J. McGrath,et al.  Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema. , 2009, Journal of dermatological science.

[12]  J. Bernstein,et al.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.

[13]  K. Bork,et al.  Kallikrein–kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[15]  K. Bork,et al.  Sudden upper airway obstruction in patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[16]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[17]  J. Weiler,et al.  A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. , 2001, Clinical immunology.

[18]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[19]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[20]  K. Skriver,et al.  CpG mutations in the reactive site of human C1 inhibitor. , 1989, The Journal of biological chemistry.

[21]  M. Cicardi,et al.  Hereditary Angioedema: An Appraisal of 104 Cases , 1982, The American journal of the medical sciences.